少年四大名捕

India’s Iconic Pilgrimage to Amarnath Shrine Resumes After Two Years - Videos_我的网站

一 |     India’s iconic pilgrimage to the Amarnath Shrine has resumed after a gap of two years as the first group of pilgrims reached Nuwan Pahalgam base camp in Anantnag District of Kashmir from Jammu on Thursday.,The Jammu and Kashmir Government had cancelled the annual Amarnath pilgrimage due to the prevailing COVID-19 situation in 2020 and 2021 after a discussion with the Amarnathji Shrine Board members.,According to photos and videos circulating online, devotees expressed happiness and excitement on being able to undertake the pilgrimage after such a long wait.,43-days long celebration of Shri Amarnath Ji Yatra begins today from both routes #Baltal and #Pahalgam #AmarnathYatra2022 pic.twitter.com/LitEg286bs— Fayaz ahmad (@fayazAniSgr) June 30, 2022,A Hindu devotee walks on crutches as he heads towards holy cave during annual Amarnath Yatra 2022 pic.twitter.com/3s7Wzk4Axi— Basit Zargar (باسط) (@basiitzargar) June 30, 2022,© Photo : Twitter/@post_himalayanAmarnath Pilgrimage Began after Gap of Two YearsAmarnath Pilgrimage Began after Gap of Two Years© Photo : Twitter/@post_himalayan,© Photo : Twitter/@DrGVSundeep_IPSDevotees of Lord Shiva Started from Jammu for Amarnath Pilgrimage on WednesdayDevotees of Lord Shiva Started from Jammu for Amarnath Pilgrimage on Wednesday© Photo : Twitter/@DrGVSundeep_IPS,The pilgrims started from Jammu on Wednesday amid tight security arrangements made by the Central Reserve Police Force (CRPF) along with the army and the local police with special emphasis on the use of over 130 sniffer dogs on the vehicles' routes heading towards the shrine. It aims to ensure a safe pilgrimage amid heightened terror threats.,Calling the pilgrimage a "symbol of the glorious tradition of Hindu culture", federal Home Minister Amit Shah extended his best wishes to all the devotees.,In a tweet in Hindi, Shah said: "Amarnath pilgrimage is a symbol of the glorious tradition of Sanatan (Hindu) culture. I extend my best wishes to all devotees going on this holy journey and wish them a smooth and happy journey. Har Har Mahadev! (Hail Lord Shiva).”,Meanwhile, Jammu and Kashmir Lieutenant Governor (LG) Manoj Sinha said the annual Amarnath pilgrimage strengthens the faith in the goodness of mankind and its successful conduct is the duty or every citizen of the Union Territory.,Want to know more? Check out our Koo & Telegram accounts!,Koo: https://www.kooapp.com/profile/sputniknews,Sputnik India: https://t.me/sputniknewsindia。    CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。

Current article:http://jfp733a.ningshunsaotuiqiao.shop/news/20260826_142796.html

Published on:22:40:36